NDC 72960-112

DAXXIFY

Botulinum Toxin Type A

DAXXIFY is a Intramuscular Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Revance Therapeutics, Inc.. The primary component is Botulinum Toxin Type A.

• Product ID: 72960-112_d9d7a7ca-f826-480a-9ab3-84912f42cc32
• NDC: 72960-112
• Product Type: Human Prescription Drug
• Proprietary Name: DAXXIFY
• Generic Name: Botulinum Toxin Type A
• Dosage Form: Injection, Powder, Lyophilized, For Solution
• Route of Administration: INTRAMUSCULAR
• Marketing Start Date: 2022-09-20
• Marketing Category: BLA /
• Application Number: BLA761127
• Labeler Name: Revance Therapeutics, Inc.
• Substance Name: BOTULINUM TOXIN TYPE A
• Active Ingredient Strength: 100 U/1.2mL
• Pharm Classes: Acetylcholine Release Inhibitor [EPC], Acetylcholine Release Inhibitors [MoA], Neuromuscular Blockade [PE], Neuromuscular Blocker [EPC]
• NDC Exclude Flag: N
• Listing Certified Through: 2023-12-31

Packaging

NDC 72960-112-01

1 VIAL, SINGLE-USE in 1 CARTON (72960-112-01) > 1.2 mL in 1 VIAL, SINGLE-USE

• Marketing Start Date: 2022-09-20
• NDC Exclude Flag: N
• Sample Package?: N

Drug Details

NDC Crossover Matching brand name "DAXXIFY" or generic name "Botulinum Toxin Type A"

NDC	Brand Name	Generic Name
72960-112	DAXXIFY	botulinum toxin type A
0299-5962	Dysport	Botulinum Toxin Type A
15054-0500	Dysport	Botulinum Toxin Type A
15054-0530	Dysport	Botulinum Toxin Type A